Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Physical activity, height, and smoking affect prostate cancer risk.

A group has developed therapies that show promise for treating cancer and various other conditions.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Scalp cooling devices need to be powerful enough to overcome heat loss and reach the right temperature to prevent hair loss from chemotherapy.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.